Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

2.

Resection for Early Liver Cancer Tied to Improved Survival.

3.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

4.

Oncology Drug Shortages Persist, but Continue to Evolve

5.

High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot